Home NDC 0615-7640 Lisinopril
Product NDC 0615-7640
11-digit product format 006157640
Labeler code 0615
Product ID 0615-7640_35e2befc-faf9-486b-97d3-71f98e7e6982
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Lisinopril
Dosage form TABLET, FILM COATED
Route ORAL
Labeler NCS HealthCare of KY, Inc dba Vangard Labs
Application ANDA078402
Marketing category ANDA
Marketing start 2007-04-19
Marketing end 0000-00-00
Substance LISINOPRIL
Active strength 5 mg/1
Pharmacologic classes Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 2 · 76 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0615-7640-31 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0615-7640-05 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0615-7640-39 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0615-7640-31 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0615-7640-05 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0615-7640-39 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 0615-7640-31 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 0615-7640-05 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 0615-7640-39 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 0615-7640-31 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 0615-7640-05 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 0615-7640-39 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 0615-7640-31 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 0615-7640-05 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 0615-7640-39 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 0615-7640-31 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 0615-7640-05 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 0615-7640-39 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 0615-7640-31 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 0615-7640-05 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 0615-7640-39 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 0615-7640-31 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 0615-7640-05 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 0615-7640-39 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 0615-7640-31 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 0615-7640-05 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 0615-7640-39 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 0615-7640-31 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 0615-7640-05 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 0615-7640-39 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 0615-7640-31 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 0615-7640-05 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 0615-7640-39 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 0615-7640-31 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 0615-7640-05 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 0615-7640-39 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 0615-7640-31 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 0615-7640-05 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 0615-7640-39 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 0615-7640-31 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 0615-7640-05 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 0615-7640-39 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 0615-7640-31 I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 0615-7640-05 I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 0615-7640-39 I Inactivated by FDA bd6a592717d7…303034d00443…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 6 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A078402-001 LISINOPRIL LISINOPRIL 2.5MG TABLET / ORAL AB 2007-04-19 A078402-002 LISINOPRIL LISINOPRIL 5MG TABLET / ORAL AB 2007-04-19 A078402-003 LISINOPRIL LISINOPRIL 10MG TABLET / ORAL AB 2007-04-19 A078402-004 LISINOPRIL LISINOPRIL 20MG TABLET / ORAL AB 2007-04-19 A078402-005 LISINOPRIL LISINOPRIL 30MG TABLET / ORAL AB 2007-04-19 A078402-006 LISINOPRIL LISINOPRIL 40MG TABLET / ORAL AB 2007-04-19
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 6 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 7 · 252 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A078402-001 LISINOPRIL 2.5MG TABLET / ORAL AB 2007-04-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A078402-002 LISINOPRIL 5MG TABLET / ORAL AB 2007-04-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A078402-003 LISINOPRIL 10MG TABLET / ORAL AB 2007-04-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A078402-004 LISINOPRIL 20MG TABLET / ORAL AB 2007-04-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A078402-005 LISINOPRIL 30MG TABLET / ORAL AB 2007-04-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A078402-006 LISINOPRIL 40MG TABLET / ORAL AB 2007-04-19 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A078402-001 LISINOPRIL 2.5MG TABLET / ORAL AB 2007-04-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A078402-002 LISINOPRIL 5MG TABLET / ORAL AB 2007-04-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A078402-003 LISINOPRIL 10MG TABLET / ORAL AB 2007-04-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A078402-004 LISINOPRIL 20MG TABLET / ORAL AB 2007-04-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A078402-005 LISINOPRIL 30MG TABLET / ORAL AB 2007-04-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A078402-006 LISINOPRIL 40MG TABLET / ORAL AB 2007-04-19 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A078402-001 LISINOPRIL 2.5MG TABLET / ORAL AB 2007-04-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A078402-002 LISINOPRIL 5MG TABLET / ORAL AB 2007-04-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A078402-003 LISINOPRIL 10MG TABLET / ORAL AB 2007-04-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A078402-004 LISINOPRIL 20MG TABLET / ORAL AB 2007-04-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A078402-005 LISINOPRIL 30MG TABLET / ORAL AB 2007-04-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A078402-006 LISINOPRIL 40MG TABLET / ORAL AB 2007-04-19 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A078402-001 LISINOPRIL 2.5MG TABLET / ORAL AB 2007-04-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A078402-002 LISINOPRIL 5MG TABLET / ORAL AB 2007-04-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A078402-003 LISINOPRIL 10MG TABLET / ORAL AB 2007-04-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A078402-004 LISINOPRIL 20MG TABLET / ORAL AB 2007-04-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A078402-005 LISINOPRIL 30MG TABLET / ORAL AB 2007-04-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A078402-006 LISINOPRIL 40MG TABLET / ORAL AB 2007-04-19 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A078402-001 LISINOPRIL 2.5MG TABLET / ORAL AB 2007-04-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A078402-002 LISINOPRIL 5MG TABLET / ORAL AB 2007-04-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A078402-003 LISINOPRIL 10MG TABLET / ORAL AB 2007-04-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A078402-004 LISINOPRIL 20MG TABLET / ORAL AB 2007-04-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A078402-005 LISINOPRIL 30MG TABLET / ORAL AB 2007-04-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A078402-006 LISINOPRIL 40MG TABLET / ORAL AB 2007-04-19 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A078402-001 LISINOPRIL 2.5MG TABLET / ORAL AB 2007-04-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A078402-002 LISINOPRIL 5MG TABLET / ORAL AB 2007-04-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A078402-003 LISINOPRIL 10MG TABLET / ORAL AB 2007-04-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A078402-004 LISINOPRIL 20MG TABLET / ORAL AB 2007-04-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A078402-005 LISINOPRIL 30MG TABLET / ORAL AB 2007-04-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A078402-006 LISINOPRIL 40MG TABLET / ORAL AB 2007-04-19 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A078402-001 LISINOPRIL 2.5MG TABLET / ORAL AB 2007-04-19 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A078402-002 LISINOPRIL 5MG TABLET / ORAL AB 2007-04-19 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A078402-003 LISINOPRIL 10MG TABLET / ORAL AB 2007-04-19 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A078402-004 LISINOPRIL 20MG TABLET / ORAL AB 2007-04-19 03ed91905a0d…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 7 · 252 observed states.
FDA-Initiated Inactive NDC Indexing# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded LISINOPRIL ACTIVE INGREDIENT E7199S1YWR LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 12 LISINOPRIL ANHYDROUS ACTIVE MOIETY 7Q3P4BS2FD LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 12 BROWN IRON OXIDE INACTIVE INGREDIENT 1N032N7MFO LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 12 CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE INACTIVE INGREDIENT O7TSZ97GEP LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 12 CORN STARCH 3-E-DODECENYL SUCCINIC ANHYDRIDE MODIFIED INACTIVE INGREDIENT QG4MW19XYX LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 12 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 12 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 12 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 12 MANNITOL INACTIVE INGREDIENT 3OWL53L36A LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 12 POVIDONES INACTIVE INGREDIENT FZ989GH94E LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 12 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 LISINOPRIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 12